A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence

Addiction

Volumn 97, Issue 10, 2002, Pages 1241-1249

  Kirchmayer, Ursula ^a,b   Davoli, Marina ^a   Verster, Annette D ^a   Amato, Laura ^a   Ferri, Arica ^a   Perucci, Carlo A ^a  

^a ASL RM/E   (Italy)

^b ASL RM/E   (Italy)

Author keywords

Controlled clinical trials; Drug addiction; Maintenance; Naltrexone; Opioid; Randomized controlled trials; Review literature

Indexed keywords

DIAMORPHINE; METHADONE; NALTREXONE; OPIATE; PLACEBO;

BEHAVIOR THERAPY; COMORBIDITY; DETOXIFICATION; DRUG EFFICACY; HEALTH BEHAVIOR; HEROIN DEPENDENCE; HUMAN; MAINTENANCE THERAPY; OPIATE ADDICTION; RELAPSE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

CONTROLLED CLINICAL TRIALS; HEROIN DEPENDENCE; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0036791756     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2002.00217.x     Document Type: Review

References (52)

1. Altman, J. L., Meyer, R. E., Mirin, S. M., McNamee, H. B. & McDougle, M. (1976) Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study. International Journal of the Addictions, 11, 485-499.
2. Anton, R. A., Hogan, I., Jalali, B., Riordan, C. E. & Kleber, H. D. (1981) Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug and Alcohol Dependence, 8, 157-168.
3. Arndt, I., McLellan, A. T. & O'Brien, C. P. (1984) Abstinence treatments for opiate addicts: therapeutic community or naltrexone? NIDA Research Monograph Series, 49, 275-281.
4. Bollettino Ministero Sanità (1999) Bulletin of the Ministry of Health. Rome; Ministero della Sanita & UNICRI.
5. Bollettino Regione Lazio Sulle Tossicodipendenze (2000) Bulletin of the Lazio Region on Drug Dependence. Rome: Agency of Public Health, Latium Region.
6. Bradford, A., Hurley, F., Golodzowski, O. & Dorrier, C. (1976) Interim report on clinical intake and safety data collected from 17 NIDA-funded naltrexone studies. NIDA Research Monograph Series, 9, 163-171.
7. Brahen, L. S., Capone, T., Heller, R. C., Linden, S. L., Landy, H. J. & Lewis, M. J. (1978) Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens. American Journal of Drug and Alcohol Abuse, 5, 235-245.
8. Brahen, L. S., Capone, T., Wichert, V. & Desiderio, D. (1977) Naltrexone and cyclazocine. A controlled treatment study. Archives of General Psychiatry, 34, 1181-1184.
9. Brahen, L. S., Capone, T. & Wojak, J. C. (1979) The double-blind crossover trial design: how good is it for psychoactive drugs? American Journal of Drug and Alcohol Abuse, 6, 189-196.
10. Callahan, E. J., Rawson, R. A., McC., Leave, B., Arias, R., Glazer, M. & Liberman, R. P. (1980) The treatment of heroin addiction: naltrexone alone and with behavior therapy. International Journal of the Addictions, 15, 795-807.
11. Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift, B. & O'Brien, C. P. (1997) Naltrexone pharmacotherapy for opioid dependent federal probationers. Journal of Substance Abuse Treatment, 6, 529-534.
12. Crowley, T. J., Wagner, J. E., Zerbe, G. & Macdonald, M. (1985) Naltrexone-induced dysphoria in former opioid addicts. American Journal of Psychiatry, 142, 1081-1084.
13. Curran, S. & Savage, C. (1976) Patients response to naltrexone: issues of acceptance, treatment effects and frequency of administration. NIDA Research Monograph Series, 9, 67-69.
14. D'Ippoliti, D., Davoli, M., Bargagli, A. M., Pasqualini, F. & Perucci, C. A. (1996) Characteristics and outcome of interventions offered to drug users attending public treatment centers in Lazio. Epidemiologia E Prevenzione, 20, 37-43.
15. Davoli, M., Ferri, M., Ali, R., Faggiano, F., Farrell, M., Mattick, R. & Auriacombe, M. (2000) The Cochrane review group on drug and alcohol. Addiction, 95, 10.
16. Du Pont Pharmaceuticals (1990) Trexan in Opioid Addiction. DuPont Product Monograph, Wilmington, DE: E. I. Du Pont de Nemours & Co., (Inc.).
17. Ferri, M., Davoli, M., Ali, R., Auriacombe, M., Chengzheng, Z., Faggiano, F., Farrell, M., Foxcroft, D., Ling, W. & Mattick, R. (2002) Cochrane drugs and alcohol group. In: The Cochrane Library. Issue 2, Oxford: Update Software.
18. Gonzales, J. P. & Brodgen, R. N. (1988) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 35, 192-213.
19. Greenstein, R. A., Arndt, I. C., McLellan, A. T., O'Brien, C. P. & Evans, B. (1984) Naltrexone: a clinical perspective. Journal of Clinical Psychiatry, 45, 25-28.
20. Grey, C., Oosborn, E. & Reznikoff, M. (1986) Psychosocial factors in outcome in two opioid addiction treatments, Journal of Clinical Psychology, 42, 185-189.
21. Hollister, L. E. (1978) Clinical evaluation of naltrexone treatment of opiate dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Archives of General Psychiatry, 35, 335-340.
22. Hollister, L. E., Schwin, R. L. & Kasper, P. (1977) Naltrexone treatment of opiate-dependent persons. Drug and Alcohol Dependence, 2, 203-209.
23. Hurzeler, M., Gerwitz, D. & Kleber, H. (1976) Varying clinical contexts for administering naltrexone, NIDA Research Monograph Series, 9, 48-66.
24. Jepsen, P. W. (1990) Naltrexone: an opioid antagonist to support the drug-free state in previous opioid addicts having stopped the habit. Ugeskrift for Laeger, 152, 2546-2549.
25. Judson, B. A., Carney, T. M. & Goldstein, A. (1981) Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison. Drug and Alcohol Dependence, 7, 325-346.
26. Judson, B. A. & Goldstein, A. (1984) Naltrexone treatment of heroin addiction: one-year follow-up. Drug and Alcohol Dependence, 13, 357-365.
27. Judson, B. A., Goldstein, A. & Inturrisi, C. E. (1983) Methadyl acetate (LAAM) in the treatment of heroin addicts. Archives of General Psychiatry, 40, 834-840.
28. Ladewig, D. (1990) Naltrexone-an effective aid in the psychosocial rehabilitation process of former opiate dependent patients. Therapeutische Umschau, 47, 247-250.
29. Lerner, A., Sigal, M., Bacalu, A., Shiff, R., Burganski, I. & Gelkopf, M. (1992) A naltrexone double-blind placebo controlled study in Israel, Israel Journal of Psychiatry and Related Sciences, 29, 36-43.
30. Lewis, D. C., Mayer, J., Hersch, R. G. & Black, R. (1978) Narcotic antagonist treatment: clinical experience with naltrexone. International Journal of the Addictions, 13, 961-973.
31. Ling, W. (1978) Naltrexone: the clinical investigator's dilemma. NIDA Research Monograph Series, 19, 308-314.
32. Ling, W. & Wesson, D. R. (1984) Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience, Journal of Clinical Psychiatry, 45, 46-48.
33. Martin, W. R., Jasinski, D. R., Mansky, P. A. & Lexington. K. (1973) Naltrexone, an antagonist for the treatment of heroin dependence. Archives of General Psychiatry, 28, 784-791.
34. Mello, N. K., Mendelson, J. H., Kuehnle, J. C. & Sellers, M. S. (1981) Operant analysis of human heroin self-administration and the effects of naltrexone. Journal of Pharmacology and Experimental Therapy, 216, 45-54.
35. Metzger, D. S., Cornish, J., Woody, G. E., McLellan, A. T., Druley, P. & O'Brien, C. P. (1989) Naltrexone in federal probationers. NIDA Research Monograph Series, 95, 465-466.
36. Navaratnem, V., Jamaludin, A., Narayanasamy, R., Mohamed, M. & Mansor, S. M. (1994) Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts. Drug and Alcohol Dependence, 34, 231-236.
37. O'Brien, C. P., Greenstein, R. A., Mintz, J. & Woody, G. E. (1975) Clinical experience with naltrexone. American Journal of Drug and Alcohol Abuse, 2, 365-377.
38. Osborn, E., Grey, C. & Reznikoff, M. (1986) Psychosocial adjustment, modality choice and outcome in naltrexone versus methadone treatment. American Journal of Drug and Alcohol Abuse, 12, 383-388.
39. Parawatikar, S., Crawford, J., Nelpuka, J. V. & Degarcia, C. (1976) Factors influencing success in an antagonistic treatment programme. NIDA Research Monograph Series, 9, 77-81.
40. Rawson, R. A., Glazer, M., Callahan, E. J. & Liberman, R. P. (1979) Naltrexone and behavior therapy for heroin addiction. NIDA Research Monograph Series, 25, 26-43.
41. Rawson, R. A. & Tennant, F. S. Jr (1984) Five-year follow-up of opiate addicts with naltrexone and behavior therapy. NIDA Research Monograph Series, 49, 289-295.
42. Resnick, R. B., Volavka, J., Freedman, A. M. & Thoams, M. (1974) Studies of EN-1639A (naltrexone): a new narcotic antagonist, American Journal of Psychiatry, 131, 646-650.
43. Sackett, D. I. & Oxman, A. D., eds (1995) Cochrane Collaboration. Cochrane Collaboration Handbook. Oxford: The Cochrane Collaboration [updated 14 July 1995].
44. San, L., Pomarol, G., Peri, J. M., Olle, J. M. & Cami, J. (1991) Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. British Journal of Addiction, 86, 983-990.
45. Shufman, E. N., Porat, S., Witzum, E., Gandacu, D., Bar-Hamburger, R. & Ginath, Y. (1994) The efficacy of naltrexone in preventing re-abuse of heroin after detoxification. Biological Psychiatry, 35, 935-945.
46. Sideroff, S. L., Charuvastra, V. C. & Jarvik, M. E. (1978) Craving in heroin addicts maintained on the opioid antagonist naltrexone. American Journal of Drug and Alcohol Abuse, 5, 415-423.
47. Taintor, Z., Landsberg, R. & Wicks, N. (1975) Experiences with naltrexone in Buffalo. American Journal of Drug and Alcohol Abuse, 2, 391-401.
48. Tennant, F. S., Rawson, R. A., Cohen, A. J. & Mann, A. (1984) Clinical experiences with naltrexone in suburban opioid addicts. Journal of Clinical Psychiatry, 45, 42-45.
49. Volavka, J., Resnick, R. B., Kestenbaum, R. S. & Freedman, A. M. (1976) Short-term effects of naltrexone in 155 heroin ex-addicts. Biological Psychiatry, 11, 679-685.
50. Washton, A. M., Pottash, A. C. & Gold, M. S. (1984) Naltrexone in addicted business executives and physicians. Journal of Clinical Psychiatry, 45, 39-34.
51. Wikler, A. (1976) The theoretical basis of narcotic addiction treatment with narcotic antagonist. NIDA Research Monograph Series, 9, 119-122.
52. World Drug Report (1997) United Nations International Drug Control Program. Oxford: Oxford University Press.